Volume 25, Number 10—October 2019
Research
Risk Factors for Carbapenem-Resistant Pseudomonas aeruginosa, Zhejiang Province, China
Yan-Yan Hu, Jun-Min Cao, Qing Yang, Shi Chen, Huo-Yang Lv, Hong-Wei Zhou, Zuowei Wu
, and Rong Zhang
, and Rong Zhang
Table 1
Pseudomonas aeruginosa isolates obtained from hospitals in Zhejiang Province, China, 2015–2017
| Year | No. hospitals* |
No. isolates | Isolation rate, %† | Gram-negative isolates, % | Imipenem-resistant isolates, % | ||||
|---|---|---|---|---|---|---|---|---|---|
| Total | 3A | 3B | 2A | 2B | |||||
| 2015 | 78 | 41 | 23 | 13 | 1 | 22,464 | 8.1 | 11.9 | 35.4 |
| 2016 | 88 | 44 | 23 | 19 | 2 | 24,303 | 8.0 | 12.0 | 37.1 |
| 2017 |
84 |
41 |
24 |
18 |
1 |
25,113 |
7.8 |
12.0 |
39.1 |
| *Hospital classification is performed by the National Health Commission of China on the basis of the number of beds and comprehensive evaluation scores. Comprehensive evaluation covers the number of departments, staffing levels, management, technical level, work quality, and supporting facilities. Class 3 hospitals have >500 beds, class 2 hospitals have 100–499 beds. Grade levels are given on the basis of scores from a comprehensive evaluation; grade A hospitals received >900 points, grade B hospitals received 750–899 points. †P. aeruginosa was the fourth most commonly isolated pathogen in the region in each of the reported years. | |||||||||
Page created: September 17, 2019
Page updated: September 17, 2019
Page reviewed: September 17, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.